Bangladesh pharma major Globe Biotech applies for approval to run clinical trial of COVID vaccine
Bangladeshi drugmaker Globe Biotech Limited has applied for approval to begin clinical trials of its COVID-19 vaccine candidate 'Bangavax'
Jan 17, 2021
Bangladeshi drugmaker Globe Biotech Limited has applied for approval to begin clinical trials of its COVID-19 vaccine candidate 'Bangavax'.
It submitted the ethical clearance application to Bangladesh Medical Research Council (BMRC) on Sunday. An assistant director of BMRC received the application.
On behalf of Globe, CRO Limited will run the clinical trial in a unit of a government hospital. The name of the hospital will be disclosed after gaining approval.
https://bdnews24.com/health/2021/01/17/globe-biotech-applies-for-approval-to-run-clinical-trial-of-covid-vaccine
Post a Comment